Preview

Journal of Siberian Medical Sciences

Advanced search

Immunomodulating properties of the probiotic preparation, VedaBiotic in aging

https://doi.org/10.31549/2542-1174-2021-1-41-54

Abstract

The homeostatic immunological dialogue between the host and its microbiota is critical to maintaining health. The weakening of the organism occurring with age, its greater dependence on the external life conditions, make old age the period of the greatest morbidity. In the context of a progressive increase in life expectancy, more and more attention is being paid to the possibility of influencing human health through personalized nutritional and therapeutic strategies aimed at modifying the intestinal microbiota, which include the use of pro- and prebiotics.

The aim of this work is to study the effect of the VedaBiotic preparation, which is an original complex of probiotics (freeze-dried biomass of live active bifidobacteria, lactobacilli, Streptococcus thermophilus), prebiotics (microcrystalline cellulose, lactulose) and vitamin C, on the cellular immune response and functional activity of immunocytes in age-dependent mammals (male mice at the age of 10 months). It was found that in age-dependent mammals, a course administration of the drug leads to the stimulation of the proliferative activity of immunocytes and the cellular immune response, also including the case of the induced immunosuppression (when the delayed-type hypersensitivity reaction increased to the level observed in intact animals of similar age). The VedaBiotic also has a modulating effect on the cytokines production, causing a decrease in the pro-inflammatory cytokines IL-β and IFN-y, and an increase in the anti-inflammatory cytokine IL-10.

Thus, the VedaBiotic preparation has a favorable immunomodulatory effect and can be used as a nutritional supplement — as a source of probiotic microorganisms — to reduce the negative side effects of cytostatic treatment, as well as by elderly persons to improve the quality of life and to prevent the development of age-associated pathology.

About the Authors

E. V. Markova
Research Institute of Fundamental and Clinical Immunology
Russian Federation

Markova Evgeniya Valeryevna — Dr. Sci. (Med.), Professor, Chief Researcher.

14, Yadrintsevskaya str., Novosibirsk, 630099



О. V. Sorokin
VedaGenetika, LLC
Russian Federation

Sorokin Oleg Viktorovich — Cand. Sci. (Med.), Director-General.

Novosibirsk



I. A. Goldina
Research Institute of Fundamental and Clinical Immunology
Russian Federation

Goldina Irina Aleksandrovna — Researcher, Laboratory of Neuroimmunology.

Novosibirsk



I. V. Savkin
Research Institute of Fundamental and Clinical Immunology
Russian Federation

Savkin Ivan Vladimirovich — Researcher, Laboratory of Neuroimmunology.

Novosibirsk



M. A. Knyazheva
Research Institute of Fundamental and Clinical Immunology
Russian Federation

Knyazheva Maria Aleksandrovna — Junior Researcher, Laboratory of Neuroimmunology.

Novosibirsk



E. V. Serenko
Research Institute of Fundamental and Clinical Immunology
Russian Federation

Serenko Evgeniy Vladimirovich — Post-graduate Student, Laboratory of Neuroimmunology.

Novosibirsk



К. A. Bakulin
Novosibirsk State Medical University
Russian Federation

Bakulin Konstantin Aleksandrovich — Cand. Sci. (Med.), Vice-Rector for Pedagogical Work.

Novosibirsk



A. V. Molokeev
Vector-BiAlgam, JSC
Russian Federation

Мolokeev Aleksey Vladimirovich — Dr. Sci. (Bio.), Director for Science.

Koltsovo settlement, Novosibirsk Region



References

1. Landman C., Quevrain E. (2016). Gut microbiota: Description, role and pathophysiologic implications. Rev. Med. Interne, 37 (6), 418-423. doi: 10.1016/j.revmed.2015.12.012.

2. Kashtanova D.A., Egshatyan L.V., Tkacheva O.N. (2015). The involvement of human gut microbiota in chronic systemic inflammation. Clin. Microbiology and Antimicrobial Chemotherapy, 17 (4), 310-317.

3. Nikonova E.L., Popova E.N. (2019). Microbiota. Moscow, 256 p. In Russ.

4. Belkaid Y., Harrison O. J. (2017). Homeostatic immunity and the microbiota. Immunity, 46 (4), 562-576. doi: 10.1016Zj.immuni.2017.04.008.

5. Lin L., Zhang J. (2017). Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunology, 18: 2. doi: 10.1186/s12865-016-0187-3.

6. Agace W.W., McCoy K.D. (2017). Regionalized development and maintenance of the intestinal adaptive immune landscape. Immunity, 46 (4), 532-548. doi: 10.1016/j.immuni.2017.04.004.

7. Bagirov N.S., Petukhov I.N., Dmitriev N.V., Grigo-ryevskaya Z.V. (2018). The microbiome and cancer: is there a connection? A literature review. Malignant Tumors, 8 (3s1), 22-26. doi: 10.18027/2224-5057-2018-8-3s1-22-26. In Russ.

8. Markova E.V. (2012). Immune System and Higher Nervous Activity. Mechanisms of Neuroimmune Interactions in the Implementation and Regulation of Behavioral Responses. Saarbruken, 258 p. In Russ.

9. Markova E.V., Knyazheva M.A., Rumina T.V., Kozlov V.A. (2014). Immune cells functioning features in individuals with aggressive- and depressive-like behaviors. Siberian Journal of Life Sciences and Agriculture, 8 (56), 131-147. In Russ.

10. Yoshikai Y., Miake S., Matsumoto T., Nomoto K., Takeya K. (1979). Effect of stimulation and blockade of mononuclear phagocyte system on the delayed footpad reaction to SRBC in mice. Immunology, 38 (3), 577-583.

11. Sergeeva E.V. (2010). The status of immunity of elderly people. Human Ecology, 5, 55-58.

12. Markova E.V., Obukhova L.A., Kolosova N.G. (2003). Activity of cell immune response and open field behavior in Wistar and OXYS rats. Bull. Exp. Biol. Med., 136 (4), 377-379.

13. Markova E.V., Obukhova L.A., Kolosova N.G. (2003). Parameters of cell immune response in Wistar and OXYS rats and their behavior in the open field test. Bull. Exp. Biol. Med., 136 (6), 588-590.

14. Crooke S.N., Ovsyannikova I.G., Poland G.A., Kennedy R.B. (2019). Immunosenescence and human vaccine immune responses. Immun. Ageing, 16: 25. doi: 10.1186/s12979-019-0164-9.

15. Goronzy J.J., Weyand C.M. (2013). Understanding immunosenescence to improve responses to vaccines. Nat. Immunol., 14 (5), 428-436. doi: 10.1038/ni.2588.

16. Vorontsova Z.A., Nikityuk D.B., Kudaeva E.F. (2016). Gut associated lymphoid tissue as information and corrective system of extreme conditions (brief literature report). Journal of New Medical Technologies, eEdition, 4. doi: 10.12737/21854.

17. Cicin-Sain L., Messaoud I., Park B. et al. (2007). Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc. Natl. Acad. Sci. USA, 104, 19960-19965. doi: 10.1073/pnas.0705905104.

18. Tsukamoto H., Clise-Dwyer K., Huston G.E. et al. (2009). Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects. Proc. Natl. Acad. Sci. USA., 106 (43), 18333-18338. doi: 10.1073/pnas.0910139106.

19. Maslowski K.M., Vieira A.T., Ng A. et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461, 1282-1286.

20. Meijer K., de Vos P., Priebe M.G. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health. Curr. Opin. Clin. Nutr. Metab. Care., 13 (6), 715-721. doi: 10.1097/MCO.0b013e32833eebe5.

21. Hamer H.M., Jonkers D., Venema K. et al. (2008). Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther., 27, 104-119. doi: 10.1111/j.1365-2036.2007.03562.x.

22. Faty А., Ferre Р., Commans S. (2012). The acute phase protein serum amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways. PLoS One., 7 (4), e34031. doi: 10.1371/journal.pone.0034031.

23. Piccirillo C.A., Shevach E.M. (2004). Naturally-occurring CD4+CD25+ immunoregulatory T-cells: central players in the arena of peripheral tolerance. Semin. Immunol., 16 (2), 81-88.

24. Pronio A., Montesani C., Butteroni C. et al. (2008). Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm. Bowel. Dis., 14, 662-668.

25. Eliseeva D.D., Zavalishin I.A., Karaulov A.V., Bykovs-kaiy S.N. (2012). The role of regulatory T-cells in the development of autoimmune process in multiple sclerosis. Annals of the Russ. Academy of Medical Sciences, 3, 68-74.

26. Bettelli E., Dastrange M., Oukka M. (2005). Foxp3 interacts with nuclear factor of activated T cells and NF-kappa to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA., 102, 5138-5143.

27. Shpagina L.A., Gerasimenko O.N., Gorobey A.M. et al. (2020). The role of multisymbiotics in the comprehensive treatment of older patients. Siberian Medical Bulletin, 3, 50-54.


Review

For citations:


Markova E.V., Sorokin О.V., Goldina I.A., Savkin I.V., Knyazheva M.A., Serenko E.V., Bakulin К.A., Molokeev A.V. Immunomodulating properties of the probiotic preparation, VedaBiotic in aging. Journal of Siberian Medical Sciences. 2021;(1):41-54. https://doi.org/10.31549/2542-1174-2021-1-41-54

Views: 307


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2542-1174 (Print)